PharmaCare takes its name from the combination of “Pharma” (pharmaceuticals) and “Care”, symbolizing our commitment to pharmaceuticals and a healthier world.

Pharmacare is an integrated service provider specializing in the internationalization, regulatory technical consulting and sales of pharmaceutical products. We provide one-stop empowered cooperation covering product selection, market positioning, GMP certification, CTD dossier compilation, international registration and global sales. With long-term dedication to emerging markets and accelerated layout in regulatory markets, Pharmacare leverages a unique business model to connect Chinese pharmaceutical products with global pharmaceutical markets.

Our business covers more than 60 countries across five continents. We have obtained over 100 domestic and overseas registration certificates for pharmaceutical formulations and APIs (Active Pharmaceutical Ingredients). We have built close business partnerships with more than 100 professional pharmaceutical manufacturers and distributors at home and abroad, including many renowned pharmaceutical enterprises. The company holds exclusive domestic and overseas sales rights for a wide range of formulations and APIs. Driven by business expansion, we have successively established branches in Brazil, Hong Kong, the Netherlands, Thailand and other locations to build a localized overseas operation network.

Pharmacare has an international, professional, young and highly educated team, comprising veteran pharmaceutical business specialists, experts proficient in domestic and international pharmaceutical registration regulations, as well as project management teams with rich experience in international risk control and capital operation.

Ten years of continuous cultivation has laid a solid foundation for our development. The company has achieved rapid and sustained business growth in recent years. We will further increase investment in the registration of pharmaceutical formulations, APIs and other products. At the same time, we are committed to building an international brand and expanding our overseas sales team. While consolidating exports of pharmaceutical formulations and APIs to emerging markets, we will accelerate development of mid-to-high-end international markets including Europe, the MENA region, Southeast Asia, the Americas and Oceania.